| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/23/1992 | CA2061507A1 Immunogens derived from pathogen-free tick species or cell lines, and tick vaccines derived thereform |
| 09/22/1992 | WO1992016659A1 Element and method for nucleic acid amplification and detection using adhered probes |
| 09/22/1992 | WO1992016630A1 Dna sequences which code for virulence characteristics of streptococcus suis and parts thereof, polypeptides and antibodies derived therefrom and the use thereof for the diagnosis of and protection against infection by s. suis in mammals, including man |
| 09/22/1992 | US5149797 Method of site-specific alteration of rna and production of encoded polypeptides |
| 09/22/1992 | US5149796 Chimeric DNA-RNA catalytic sequences |
| 09/22/1992 | US5149785 Proteins which regulate gene expression of the interleukin-2 receptor and of human lymphotropic retroviruses |
| 09/22/1992 | US5149783 Polypeptide capable of being cleaved by protease of rhinovirus for use as a test system for inhbitors of viral proteases and an assay for identifying viral inhibitors |
| 09/22/1992 | US5149781 Steroid/thyroid hormone receptor-related gene inappropriately expressed in human hepatocellular carcinoma |
| 09/22/1992 | US5149777 Human insulin analogs and preparations containing them |
| 09/22/1992 | US5149657 Escherichia coli expression vector encoding bioadhesive precursor protein analogs comprising three to twenty repeats of the decapeptide (Ala-Lys-Pro-Ser-Tyr-Pro-Pro-Thr-Tyr-Lys) |
| 09/22/1992 | US5149655 Apparatus for genetic transformation |
| 09/22/1992 | US5149645 Infecting mono or dicotyledons plants of liliaceae or amaryllidaceae family or protoplast with tumor provoking strains of agrobacterium ; genetic engineering |
| 09/22/1992 | US5149644 Process for the release of poly(3-hydroxy carboxylic acids) |
| 09/22/1992 | US5149639 Norerythromycin |
| 09/22/1992 | US5149638 Tylosin biosynthetic genes tylA, tylB and tylI |
| 09/22/1992 | US5149636 Transforming dna of cells to generate multiple copies of foreign dna, recovering cells capable of producing desired pro protein and cloning |
| 09/22/1992 | US5149635 Messenger RNA stabilization in animal cells |
| 09/22/1992 | US5149628 Nucleic acid probe used for diagnosis of cancer |
| 09/22/1992 | US5149533 Genetically engineered human tissue plasminogen activator having increased half-life, and increased clot lysis activity and greater specificity for binding fibrin |
| 09/22/1992 | US5149532 Transforming lactobacillus by recombinant DNA technology to express herpes virus glycoprotein D, growing lactobacillus in culture media, harvesting by separation |
| 09/22/1992 | CA2083173A1 Element and method for nucleic acid amplification and detection using adhered probes |
| 09/22/1992 | CA2062377A1 Method for detection of neuroactive substances |
| 09/22/1992 | CA1307753C Dna sequences, recombinant dna molecules and processes for producing mullerian inhibiting substance-like polypeptides |
| 09/22/1992 | CA1307752C Immunoaffinity purification system |
| 09/20/1992 | WO1992016546A1 Response element compositions and assays employing same |
| 09/20/1992 | CA2100584A1 Response element compositions and assays employing same |
| 09/20/1992 | CA2063316A1 Dna and amino acid sequence of penicillin binding protein 2a from staphylococcus aureus strain 27r and derivatives for use in purification thereof and assay for compounds effective against methicillin resistant organisms |
| 09/19/1992 | WO1992016658A1 Response element compositions and assays employing same |
| 09/19/1992 | WO1992016640A1 Oligosaccharide enzyme substrates and inhibitors: methods and compositions |
| 09/19/1992 | CA2736076A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
| 09/19/1992 | CA2100582A1 Response element compositions and assays employing same |
| 09/17/1992 | WO1992015702A1 The biological selection of useful molecules |
| 09/17/1992 | WO1992015699A1 High affinity humanized monoclonal antibodies |
| 09/17/1992 | WO1992015694A1 Flp-mediated gene modification in mammalian cells, and compositions and cells useful therefor |
| 09/17/1992 | WO1992015691A1 Biocidal proteins |
| 09/17/1992 | WO1992015690A1 Nematode control with proteinase inhibitors |
| 09/17/1992 | WO1992015689A1 Expression of recombinant proteins in attenuated bacteria |
| 09/17/1992 | WO1992015688A1 Production of recombinant proteins |
| 09/17/1992 | WO1992015687A1 Fused genes and their use for determining the presence of metals or of xenobiotic compounds |
| 09/17/1992 | WO1992015686A1 Modified factor vii |
| 09/17/1992 | WO1992015685A1 Production of plants resistant to attacks of sclerotinia sclerotiorum by introducing a gene coding for an oxalate oxidase |
| 09/17/1992 | WO1992015684A1 RECOMBINANT FIV GLYCOPROTEIN 160 AND p24 GAG PROTEIN |
| 09/17/1992 | WO1992015680A1 Methods and compositions for the selective inhibition of gene expression |
| 09/17/1992 | WO1992015678A1 Pcr generated dicistronic dna molecules for producing antibodies |
| 09/17/1992 | WO1992015677A1 Process for the development of binding mini-proteins |
| 09/17/1992 | WO1992015676A1 Somatic cell gene therapy |
| 09/17/1992 | WO1992015673A1 Cloning and expression of renilla luciferase |
| 09/17/1992 | WO1992015672A1 Genetically engineered vaccine strain |
| 09/17/1992 | WO1992015671A1 Soluble cd28 proteins and methods of treatment therewith |
| 09/17/1992 | WO1992015613A1 Improved preparation of cat dander allergens for immunotherapeutic purposes and uses therefor |
| 09/17/1992 | WO1992015612A1 Curculin b, dna coding for the same, and production of both of them |
| 09/17/1992 | WO1992015605A2 Inhibitors of human neutrophil elastase and human cathepsin g |
| 09/17/1992 | WO1992015603A1 Prad1 cyclin and its cdna |
| 09/17/1992 | WO1992015600A1 Cancer diagnosis and therapy |
| 09/17/1992 | WO1992015597A1 Extraction system |
| 09/17/1992 | WO1992015328A1 Attenuated, genetically-engineered pseudorabies virus s-prv-155 and uses thereof |
| 09/17/1992 | WO1992015327A1 Recombinant double chain immunotoxins |
| 09/17/1992 | WO1992015323A1 Protein-induced morphogenesis |
| 09/17/1992 | WO1992015322A1 Redirection of cellular immunity by receptor chimeras |
| 09/17/1992 | WO1992015320A1 Antigen recognized by patients with antibody associated paraneoplastic sensory neuronopathy, dna encoding same and uses thereof |
| 09/17/1992 | WO1992015195A1 Insecticidally effective peptides |
| 09/17/1992 | WO1992013553A3 Method and agents for promoting wound healing |
| 09/17/1992 | WO1992013072A3 Process for the synthesis and purification of human ciliary neuronotrophic factor (cntf) from escherichia coli |
| 09/17/1992 | WO1992013053A3 Detergent compositions with high activity cellulase and softening clays |
| 09/17/1992 | CA2108144A1 Methods and compositions for the selective inhibition of gene expression |
| 09/17/1992 | CA2107234A1 Nematode control with proteinase inhibitors |
| 09/17/1992 | CA2106092A1 Biocidal proteins |
| 09/17/1992 | CA2105986A1 Extraction system |
| 09/17/1992 | CA2103901A1 Insecticidally effective peptides isolatable from diguetia spider venom |
| 09/16/1992 | WO1992016623A2 Receptors for bombesin-like peptides |
| 09/16/1992 | EP0503950A2 Method of purifying recombinant hepatitis B virus surface proteins from recombinant cells |
| 09/16/1992 | EP0503648A1 CD2-Binding domain of lymphocyte function associated antigen 3 |
| 09/16/1992 | EP0503484A2 Monoclonal antibodies as antidotes |
| 09/16/1992 | EP0503346A2 Method of improvement of stability of high alkaline proteases |
| 09/16/1992 | EP0503297A1 GLIA activating factor and its production |
| 09/16/1992 | EP0503252A2 Recombinant proteins having the immunoreactivity of Hepatitis B virus e antigens (HBeAg), method for their production and their application in immunoassays and as vaccines |
| 09/16/1992 | EP0503050A1 Hybrid growth factors |
| 09/16/1992 | EP0503045A1 Cloning cartridges and expression vectors in gram-negative bacteria |
| 09/16/1992 | EP0503002A1 Antisense oligonucleotide inhibition of papillomavirus |
| 09/16/1992 | EP0502995A1 Dna, constructs, cells and plants derived therefrom. |
| 09/16/1992 | EP0502994A1 Detection of hpv transcripts. |
| 09/16/1992 | EP0502962A1 Hirudine polyalkylene glycol conjugates. |
| 09/16/1992 | EP0502928A1 METHODS OF DETECTING COLLAGEN DEGRADATION -i(IN VIVO). |
| 09/16/1992 | EP0502927A1 Dna segment encoding a gene for a receptor related to the epidermal growth factor receptor |
| 09/16/1992 | EP0502892A1 THE HUMAN C3b/C4b RECEPTOR (CR1) |
| 09/16/1992 | EP0497885A4 Array-type multiple cell injector |
| 09/16/1992 | EP0267224B1 Process for the production of a polypeptide |
| 09/16/1992 | EP0187814B1 Diagnostic assay for inhibitor or tissue-type and urokinase-type plasminogen activators |
| 09/16/1992 | EP0131624B1 Plasmids for transforming plant cells |
| 09/16/1992 | CA2105306A1 Receptors for bombesin-like peptides |
| 09/16/1992 | CA2062460A1 A method of stabilizing recombinant hepatitis b virus surface proteins from recombinant host cells |
| 09/15/1992 | WO1992016644A1 Means for in-vitro diagnosis of constituents of cytoplasmic granules and biological applications |
| 09/15/1992 | WO1992016643A1 Recombinant hybrid porin epitopes |
| 09/15/1992 | WO1992016635A1 Expression of genes in transgenic plants |
| 09/15/1992 | WO1992016627A1 Recombinant anticoccidial vaccine |
| 09/15/1992 | WO1992016228A1 TGF-β1/β2: A NOVEL CHIMERIC TRANSFORMING GROWTH FACTOR-BETA |
| 09/15/1992 | WO1991013989A1 Methods and compositions for the treatment of malignancies in which a protein kinase is associated |
| 09/15/1992 | US5147800 Host expressing ngoaiii restriction endonuclease and modification methylase from neisseria |
| 09/15/1992 | US5147792 Method of shifting the fatty acid distribution in plastids towards shorter-chained species by using thioesterase II and acyl carrier protein |
| 09/15/1992 | US5147790 Tissue plasminogen activator, biosynthesis |